CD200-CD200R as a myeloid immune checkpoint in solid tumors: mechanisms, context-dependent functions, and therapeutic opportunities.

Sahu MR, Ezhil I, Akkanapally V, Kumar A, Liu JQ, Basu S

Open source

DOI
10.3389/fimmu.2026.1950382
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1950382,
  title = {CD200-CD200R as a myeloid immune checkpoint in solid tumors: mechanisms, context-dependent functions, and therapeutic opportunities.},
  author = {Sahu MR and Ezhil I and Akkanapally V and Kumar A and Liu JQ and Basu S},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1950382},
  url = {https://doi.org/10.3389/fimmu.2026.1950382}
}

RIS

TY  - JOUR
TI  - CD200-CD200R as a myeloid immune checkpoint in solid tumors: mechanisms, context-dependent functions, and therapeutic opportunities.
AU  - Sahu MR
AU  - Ezhil I
AU  - Akkanapally V
AU  - Kumar A
AU  - Liu JQ
AU  - Basu S
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1950382
UR  - https://doi.org/10.3389/fimmu.2026.1950382
ER  - 

APA

MR, S., I, E., V, A., A, K., JQ, L., & S, B. (2026). CD200-CD200R as a myeloid immune checkpoint in solid tumors: mechanisms, context-dependent functions, and therapeutic opportunities.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1950382

Source records